DGX Financial Facts
Total non-operating expenses, net: -33MNet income: 1.37
See Full Income Statement
Additional paid-in capital: 2.53B
Total stockholders' equity: 4.69B
See Full Balance Sheet
Quest Diagnostics (DGX) Earnings
|
Expand Research on DGX
| Next EPS Date | 7/22/26 *Est. | EPS Growth Rate | -100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +2.7% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +3.2% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/28/26  |
Q126 | N/A | $2.37 | N/A | N/A | $2.83B | = | N/A | N/A | ||
| 2/10/26 | Q425 | $2.42 | $2.36 | +$0.06 | $2.81B | $2.75B | = |  | | Details | |
| 10/21/25 | Q325 | $2.60 | $2.50 | +$0.10 | $2.82B | $2.73B | = | | | Details | |
| 7/22/25 | Q225 | $2.62 | $2.57 | +$0.05 | $2.76B | $2.73B | = | | | Details | |
| 4/22/25 | Q125 | $2.21 | $2.16 | +$0.05 | $2.65B | $2.64B | = | | | Details | |
| 1/30/25 | Q424 | $2.23 | $2.19 | +$0.04 | $2.62B | $2.58B | = | | | Details | |
| 10/22/24 | Q324 | $2.30 | $2.26 | +$0.04 | $2.49B | $2.43B | = | | | Details | |
| 7/23/24 | Q224 | $2.35 | $2.33 | +$0.02 | $2.4B | $2.39B | = | | | Details |
